Poliomyelitis prevention

Recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine

N. A. Halsey, P. J. Chesney, M. A. Gerber, D. S. Gromisch, S. Kohl, S. M. Marcy, M. I. Marks, D. L. Murray, Jr Overall, L. K. Pickering, R. J. Whitley, R. Yogev, G. Peter, C. B. Hall, R. Breiman, M. C. Hardegree, R. F. Jacobs, N. E. MacDonald, W. A. Orenstein, N. R. Rabinovich & 1 others B. Schwartz

Research output: Contribution to journalReview article

34 Citations (Scopus)

Abstract

A change in the recommendations for routine immunization of children is indicated because of the reduced risk of exposure to wild-type polio viruses and the continued occurrence of vaccine-associated paralytic poliomyelitis after oral polio vaccine (OPV). All children should receive four doses of vaccine before the child enters school. Regimens of sequential inactivated polio vaccine (IPV) and OPV, IPV only, or OPV only are acceptable. Each regimen has advantages and disadvantages. In special circumstances, one of the regimens is preferred or recommended. Because logistical problems with the current childhood immunization schedule may make these new recommendations difficult to implement immediately, their adoption likely will be gradual. Nevertheless, assuming continued progress toward global eradication and the development of new combination products, the routine use of an IPV-only regime is likely to become desirable and feasible in future years.

Original languageEnglish (US)
Pages (from-to)300-305
Number of pages6
JournalPediatrics
Volume99
Issue number2
DOIs
StatePublished - Feb 1 1997

Fingerprint

Inactivated Poliovirus Vaccine
Oral Poliovirus Vaccine
Poliomyelitis
Vaccines
Inactivated Vaccines
Immunization Schedule
Immunization
Viruses

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Halsey, N. A., Chesney, P. J., Gerber, M. A., Gromisch, D. S., Kohl, S., Marcy, S. M., ... Schwartz, B. (1997). Poliomyelitis prevention: Recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine. Pediatrics, 99(2), 300-305. https://doi.org/10.1542/peds.99.2.300

Poliomyelitis prevention : Recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine. / Halsey, N. A.; Chesney, P. J.; Gerber, M. A.; Gromisch, D. S.; Kohl, S.; Marcy, S. M.; Marks, M. I.; Murray, D. L.; Overall, Jr; Pickering, L. K.; Whitley, R. J.; Yogev, R.; Peter, G.; Hall, C. B.; Breiman, R.; Hardegree, M. C.; Jacobs, R. F.; MacDonald, N. E.; Orenstein, W. A.; Rabinovich, N. R.; Schwartz, B.

In: Pediatrics, Vol. 99, No. 2, 01.02.1997, p. 300-305.

Research output: Contribution to journalReview article

Halsey, NA, Chesney, PJ, Gerber, MA, Gromisch, DS, Kohl, S, Marcy, SM, Marks, MI, Murray, DL, Overall, J, Pickering, LK, Whitley, RJ, Yogev, R, Peter, G, Hall, CB, Breiman, R, Hardegree, MC, Jacobs, RF, MacDonald, NE, Orenstein, WA, Rabinovich, NR & Schwartz, B 1997, 'Poliomyelitis prevention: Recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine', Pediatrics, vol. 99, no. 2, pp. 300-305. https://doi.org/10.1542/peds.99.2.300
Halsey, N. A. ; Chesney, P. J. ; Gerber, M. A. ; Gromisch, D. S. ; Kohl, S. ; Marcy, S. M. ; Marks, M. I. ; Murray, D. L. ; Overall, Jr ; Pickering, L. K. ; Whitley, R. J. ; Yogev, R. ; Peter, G. ; Hall, C. B. ; Breiman, R. ; Hardegree, M. C. ; Jacobs, R. F. ; MacDonald, N. E. ; Orenstein, W. A. ; Rabinovich, N. R. ; Schwartz, B. / Poliomyelitis prevention : Recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine. In: Pediatrics. 1997 ; Vol. 99, No. 2. pp. 300-305.
@article{75511694d4e24417a1bc95aee5bb2287,
title = "Poliomyelitis prevention: Recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine",
abstract = "A change in the recommendations for routine immunization of children is indicated because of the reduced risk of exposure to wild-type polio viruses and the continued occurrence of vaccine-associated paralytic poliomyelitis after oral polio vaccine (OPV). All children should receive four doses of vaccine before the child enters school. Regimens of sequential inactivated polio vaccine (IPV) and OPV, IPV only, or OPV only are acceptable. Each regimen has advantages and disadvantages. In special circumstances, one of the regimens is preferred or recommended. Because logistical problems with the current childhood immunization schedule may make these new recommendations difficult to implement immediately, their adoption likely will be gradual. Nevertheless, assuming continued progress toward global eradication and the development of new combination products, the routine use of an IPV-only regime is likely to become desirable and feasible in future years.",
author = "Halsey, {N. A.} and Chesney, {P. J.} and Gerber, {M. A.} and Gromisch, {D. S.} and S. Kohl and Marcy, {S. M.} and Marks, {M. I.} and Murray, {D. L.} and Jr Overall and Pickering, {L. K.} and Whitley, {R. J.} and R. Yogev and G. Peter and Hall, {C. B.} and R. Breiman and Hardegree, {M. C.} and Jacobs, {R. F.} and MacDonald, {N. E.} and Orenstein, {W. A.} and Rabinovich, {N. R.} and B. Schwartz",
year = "1997",
month = "2",
day = "1",
doi = "10.1542/peds.99.2.300",
language = "English (US)",
volume = "99",
pages = "300--305",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "2",

}

TY - JOUR

T1 - Poliomyelitis prevention

T2 - Recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine

AU - Halsey, N. A.

AU - Chesney, P. J.

AU - Gerber, M. A.

AU - Gromisch, D. S.

AU - Kohl, S.

AU - Marcy, S. M.

AU - Marks, M. I.

AU - Murray, D. L.

AU - Overall, Jr

AU - Pickering, L. K.

AU - Whitley, R. J.

AU - Yogev, R.

AU - Peter, G.

AU - Hall, C. B.

AU - Breiman, R.

AU - Hardegree, M. C.

AU - Jacobs, R. F.

AU - MacDonald, N. E.

AU - Orenstein, W. A.

AU - Rabinovich, N. R.

AU - Schwartz, B.

PY - 1997/2/1

Y1 - 1997/2/1

N2 - A change in the recommendations for routine immunization of children is indicated because of the reduced risk of exposure to wild-type polio viruses and the continued occurrence of vaccine-associated paralytic poliomyelitis after oral polio vaccine (OPV). All children should receive four doses of vaccine before the child enters school. Regimens of sequential inactivated polio vaccine (IPV) and OPV, IPV only, or OPV only are acceptable. Each regimen has advantages and disadvantages. In special circumstances, one of the regimens is preferred or recommended. Because logistical problems with the current childhood immunization schedule may make these new recommendations difficult to implement immediately, their adoption likely will be gradual. Nevertheless, assuming continued progress toward global eradication and the development of new combination products, the routine use of an IPV-only regime is likely to become desirable and feasible in future years.

AB - A change in the recommendations for routine immunization of children is indicated because of the reduced risk of exposure to wild-type polio viruses and the continued occurrence of vaccine-associated paralytic poliomyelitis after oral polio vaccine (OPV). All children should receive four doses of vaccine before the child enters school. Regimens of sequential inactivated polio vaccine (IPV) and OPV, IPV only, or OPV only are acceptable. Each regimen has advantages and disadvantages. In special circumstances, one of the regimens is preferred or recommended. Because logistical problems with the current childhood immunization schedule may make these new recommendations difficult to implement immediately, their adoption likely will be gradual. Nevertheless, assuming continued progress toward global eradication and the development of new combination products, the routine use of an IPV-only regime is likely to become desirable and feasible in future years.

UR - http://www.scopus.com/inward/record.url?scp=0030889783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030889783&partnerID=8YFLogxK

U2 - 10.1542/peds.99.2.300

DO - 10.1542/peds.99.2.300

M3 - Review article

VL - 99

SP - 300

EP - 305

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 2

ER -